Summary:
- The article discusses recent preclinical research investigating the blood-brain barrier (BBB) and its role in the pathogenesis of Multiple Sclerosis.
- It highlights a novel study utilizing mouse models to identify specific molecular pathways that regulate the "gateway" to the central nervous system.
- The findings suggest a potential therapeutic target that could prevent immune cell infiltration into the brain, offering a promising new avenue for managing neuroinflammatory conditions.